(19)

(11)

EP 4 313 246 A1

(12)

(43) Date of publication: 07.02.2024 Bulletin 2024/06 (21) Application number: 22781978.6 (22) Date of filing: 28.03.2022

(51) International Patent Classification (IPC):  A61M 25/10(2013.01) A61B 17/22(2006.01) A61B 17/00(2006.01) (52) Cooperative Patent Classification (CPC): A61B 2017/22098; A61B 2017/00783; A61B 2017/22061; A61M 2025/109; A61M 2025/1086; A61M 2025/105; A61M 25/1002; A61M 25/104; A61F 2/958; A61F 2/848; A61F 2002/9155; A61F 2/915 (86) International application number: PCT/US2022/022213 (87) International publication number: WO 2022/212290 (06.10.2022 Gazette 2022/40)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 29.03.2021 US 202163200794 P 03.09.2021 US 202163240811 P 09.12.2021 US 202163287813 P 22.03.2022 US 202263322372 P (71) Applicant: Elixir Medical Corporation Milpitas, CA 95035 (US)

(72) Inventors: SIRHAN, Motasim Milpitas, California 95035 (US) SERNA, Benjamyn Milpitas, California 95035 (US) YAN, John Milpitas, California 95035 (US) TREADWELL, Bozena Milpitas, California 95035 (US) (74) Representative: Clark, Jane Anne et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG London SE1 9SG (GB)